A bispecific antibody targeting the Ig domains of Siglec-E displays enhanced antitumor effects.
Zhao D, Liu M, Zeng W, Chen S, Bibi S, Wang M, Huang X, Zhu F, Zheng P, Gao Y, Wu Q, Zhang H, Cheng Q, Sun C, Bai L, Zhu Z, Li B, Wu S, Shang Y, Hasi C, Ma H, Zhou S, Jin T.
Zhao D, et al. Among authors: zeng w.
Int J Biol Macromol. 2024 Oct 15:136635. doi: 10.1016/j.ijbiomac.2024.136635. Online ahead of print.
Int J Biol Macromol. 2024.
PMID: 39419134